1. Microbial-derived products as potential new antimicrobials
- Author
-
Bruce S. Seal, Djamel Drider, Brian B. Oakley, Harald Brüssow, David Bikard, Joseph O. Rich, Stefan Miller, Estelle Devillard, Jason Kwan, Gérard Bertin, Stuart Reeves, Steven M. Swift, Margot Raicek, Cyril G. Gay, Oregon State University (OSU), Institut Charles Viollette (ICV) - ULR 7394 (ICV), Université d'Artois (UA)-Université du Littoral Côte d'Opale (ULCO)-Institut Supérieur d'Agriculture-Université de Lille-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Western University of Health Sciences, Nestlé Institute of Health Sciences SA [Lausanne, Switzerland], Biologie de Synthèse - Synthetic biology, Institut Pasteur [Paris], National Center for Agricultural Utilization Research (NCAUR), United States Department of Agriculture (USDA), Lisando GmbH, Adisseo France SAS, University of Wisconsin-Madison, Erawan consulting, Embria Health Sciences, Animal Biosciences and Biotechnology, United States Department of Agriculture, Organisation Mondiale de la Santé Animale / World Animal Health Information System (OIE-WAHIS), USDA-ARS : Agricultural Research Service, Institut Pasteur [Paris] (IP), and Organisation Mondiale de la Santé Animale / World Organisation Animal Health [Paris] (OIE)
- Subjects
0301 basic medicine ,MESH: CRISPR-Cas Systems ,[SDV]Life Sciences [q-bio] ,Antibiotics ,Review ,Antimicrobial Growth Promoters (AGPs) ,Commercialization ,Animal Diseases ,MESH: Bacteriocins ,Anti-Infective Agents ,Bacteriocins ,Drug Discovery ,Fecal Microbiome Transplants ,Bacteriophages ,Direct-fed Microbials (DFMs) ,MESH: Animals ,Animal Husbandry ,2. Zero hunger ,lcsh:Veterinary medicine ,Animal health ,MESH: Animal Husbandry ,Authorization ,Antimicrobial ,3. Good health ,MESH: Livestock ,France ,Livestock ,medicine.drug_class ,MESH: Anti-Infective Agents ,030106 microbiology ,Antimicrobial peptides ,Probiotic Development ,Biology ,03 medical and health sciences ,Antibiotic resistance ,MESH: Drug Discovery ,medicine ,Animals ,MESH: Bacteriophages ,Microbiome ,General Veterinary ,business.industry ,MESH: Animal Diseases ,Biotechnology ,MESH: France ,030104 developmental biology ,13. Climate action ,lcsh:SF600-1100 ,CRISPR-Cas Systems ,Food-animal Production ,business - Abstract
International audience; Due to the continuing global concerns involving antibiotic resistance, there is a need for scientific forums to assess advancements in the development of antimicrobials and their alternatives that might reduce development and spread of antibiotic resistance among bacterial pathogens. The objectives of the 2nd International Symposium on Alternatives to Antibiotics were to highlight promising research results and novel technologies that can provide alternatives to antibiotics for use in animal health and production, assess challenges associated with their authorization and commercialization for use, and provide actionable strategies to support their development. The session on microbial-derived products was directed at presenting novel technologies that included exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials, probiotics development via fecal microbiome transplants among monogastric production animals such as chickens and mining microbial sources such as bacteria or yeast to identify new antimicrobial compounds. Other research has included continuing development of antimicrobial peptides such as newly discovered bacteriocins as alternatives to antibiotics, use of bacteriophages accompanied by development of unique lytic proteins with specific cell-wall binding domains and novel approaches such as microbial-ecology guided discovery of anti-biofilm compounds discovered in marine environments. The symposium was held at the Headquarters of the World Organisation for Animal Health (OIE) in Paris, France during 12–15 December 2016.
- Published
- 2018
- Full Text
- View/download PDF